Authors: Grivicich, I Mans, DRA Peters, GJ Schwartsmann, G

Citation: I. Grivicich et al., Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer, BRAZ J MED, 34(9), 2001, pp. 1087-1103

Authors: Schwartsmann, G Caldas, APF Dalla Costa, T Di Leone, L Campos, O Cancela, A Schunemann, H Ferreira, AF Sander, E Mans, DRA

Citation: G. Schwartsmann et al., Phase I study of three-times daily oral etoposide in patients with refractory solid tumours, CLIN DRUG I, 19(5), 2000, pp. 375-383

Authors: da Rocha, AB Mans, DRA Lenz, G Fernandes, AK de Lima, C Monteiro, VF Goncalves, D Moreira, JCF Brunetto, AL Rodnight, R Schwartsmann, G

Citation: Ab. Da Rocha et al., Protein kinase C-mediated in vitro invasion of human glioma cells through extracellular-signal-regulated kinase and ornithine decarboxylase, PATHOBIOLOG, 68(3), 2000, pp. 113-123

Authors: Mans, DRA Di Leone, L Caldas, APF Maino, M Almeida, L Cancela, AS Grivicich, I da Rocha, AB Schwartsmann, G

Citation: Dra. Mans et al., Cellular and clinical pharmacokinetic/pharmacodynamic basis for lack of efficacy of 21-day continuous topotecan in patients with untreated advanced adenocarcinoma of the pancreas, TUMORI, 86(6), 2000, pp. 458-464

Authors: da Rocha, AB Mans, DRA Bernard, EA Ruschel, C Logullo, AF Wetmore, LA Leyva, A Schwartsmann, G

Citation: Ab. Da Rocha et al., Tamoxifen inhibits particulate-associated protein kinase C activity, and sensitises cultured human glioblastoma cells not to etoposide but to gamma-radiation and BCNU, EUR J CANC, 35(5), 1999, pp. 833-839

Authors: Mans, DRA Grivicich, I Peters, GJ Schwartsmann, G

Citation: Dra. Mans et al., Sequence-dependent growth inhibition and DNA damage formation by the irinotecan-5-fluorouracil combination in human colon carcinoma cell lines, EUR J CANC, 35(13), 1999, pp. 1851-1861